The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Franklin Templeton shares Q2 2025 results for ClearBridge All Cap Growth Portfolios: tech wins offset health care drag. See ...

Businesses have always relied on data, but they never were able to get full value out of them when they were siloed by ...